From: Imaging and clinical features of primary hepatic sarcomatous carcinoma
NO. | Age (y) | Sex | Histolgic diagnosis | Confirm | Underlying disease | AFP | CA19–9 | TNMa | Treatment after diagnosis | Follow up result |
---|---|---|---|---|---|---|---|---|---|---|
1 | 55 | M | S-ICC | Resection | CH-A | – | – | T4N0M1 | Operation | Progress (1 M) death (2 M) |
2 | 47 | M | S-ICC | Resection | CH-A | – | + | T3N0M0 | Operation | Progress (2 M) death (6 M) |
3 | 39 | M | S-HCC | Resection | CH-B | + | + | T1N0M0 | TACE and Operation | Tumor-free (16Â M) |
4 | 55 | M | S-HCC | Biopsy | Normal | – | – | T1N0M0 | TACE and RFA | Tumor-free (21 M) |
5 | 51 | M | S-HCC | Resection | CH-B | + | + | T3N1M0 | Operation and TACE | Tumor-free (12Â M) |
6 | 56 | M | S-HCC | Biopsy | CH-B | + | – | T3N1M1 | TACE | Death (4 M) |
7 | 56 | M | S-HCC | Biopsy | CH-B | – | – | T4N1M1 | TACE | Death (5 M) |
8 | 62 | F | S-HCC | Resection | CH-B | – | + | T2N0M0 | Operation | Recurrence (8 M) alive (10 M) |
9 | 60 | M | S-HCC | Resection | CH-B | + | – | T1N0M0 | Operation | Tumor-free (24 M) |
10 | 57 | M | S-HCC–CC | Resection | CH-B | + | – | T3N1M0 | Operation and PMA | Recurrence (6 M) alive (36 M) |